Search results for "Receptor binding"

showing 5 items of 25 documents

Synthesis, benzodiazepine receptor binding and molecular modelling of isochromeno[4,3-c]pyrazol-5(1H)-one derivatives

2012

Abstract A series of isochromeno[4,3-c]pyrazole-5(1H)-one derivatives 7b–h were prepared and tested at 10 μM for their ability to displace specific [3H]flunitrazepam from bovine brain membranes. The substitution pattern of the above derivatives was shown to influence the receptor affinity. The most active compound of the series was 7e, showing a 54% inhibition of [3H]flunitrazepam binding. Compounds 7a–d,i were compared with the known isomers chromeno[4,3-c]pyrazole-4(1H)-ones 14a–d,i, showing that the isochromene/chromene isomerism influences the activity.

StereochemistryProtein ConformationChemistry Techniques SyntheticIsochromeno[43-c]pirazoles Dihydrospiro[isoindole-13’-pyrazol]-3(2H)- ones Benzodiazepine receptorDrug DiscoverymedicineAnimalsHumansBenzopyransReceptorBenzodiazepine receptor bindingPharmacologyChemistryOrganic ChemistryGeneral MedicineReceptors GABA-ASettore CHIM/08 - Chimica FarmaceuticaMolecular Docking SimulationMembraneBovine brainActive compoundPyrazolesCattleFlunitrazepam bindingFlunitrazepammedicine.drugProtein Binding
researchProduct

Ein Bindungsstellenmodell für H2-Antagonisten vom 4-Pyrimidinon-Typ

1985

In einer Reihe von 17 Histamin-H2-antagonistisch wirksamen 5-substituierten 4-Pyrimidinonen wird durch Berechnung von Wechselwirkungsenergien ein Modell fur die Rezeptorbindungsstelle des Substituenten am C-5 des Pyrimidinons vorgeschlagen. Als Bindungsstelle fungiert die Aminosaure Arginin. A Binding Site Model for H2-Receptor Antagonists of the 4-Pyrimidone Type Based on calculations of the energies of interaction for a series of seventeen 5-substituted 4-pyrimidones with H2-antagonistic activity, a receptor binding site model for substituents at C-5 of the pyrimidone ring is proposed. The binding site is modeled using the amino acid arginine.

chemistry.chemical_classificationchemistry.chemical_compoundchemistryArginineStereochemistryDrug DiscoveryPharmaceutical SciencePyrimidoneBinding siteReceptor binding siteAmino acidArchiv der Pharmazie
researchProduct

DEVELOPMENT AND QUALIFICATION OF BIOANALYTICAL METHODS FOR DEAMIDATED IFNβ-1a AND INVESTIGATION ABOUT THE MECHANISM OF ACTION

2021

Interferon beta-1a (IFNβ-1a) is a recombinant IFNβ with the tradename Rebif involved in several biological activities. Recently, it has been reported that artificial deamidation of IFNb-1a increases its biological response. Given the therapeutical potential, an investigation on the deamidated variant has been carried out via different approaches to discover the mechanism underlying this biological effect. The antiviral and immunomodulatory activity of deamidated cytokine was assessed using two precise and accurate cell-based assays. As expected, deamidated IFNβ-1a showed an increase in the biological response and its canonical pathway and receptor binding affinity were thorough analysed. De…

interferon beta Mode of action Biological activity receptor binding
researchProduct

Receptor Recognition Sites of Cytokines Are Organized as Exchangeable Modules

1999

Interleukin-6 (IL-6) and ciliary neurotrophic factor (CNTF) are "4-helical bundle" cytokines of the IL-6 type family of neuropoietic and hematopoietic cytokines. IL-6 signals by induction of a gp130 homodimer (e.g. IL-6), whereas CNTF and leukemia inhibitory factor (LIF) signal via a heterodimer of gp130 and LIF receptor (LIFR). Despite binding to the same receptor component (gp130) and a similar protein structure, IL-6 and CNTF share only 6% sequence identity. Using molecular modeling we defined a putative LIFR binding epitope on CNTF that consists of three distinct regions (C-terminal A-helix/N-terminal AB loop, BC loop, C-terminal CD-loop/N-terminal D-helix). A corresponding gp130-bindin…

medicine.medical_specialtybiologyLeukemia inhibitory factor receptorCell BiologyCiliary neurotrophic factorGlycoprotein 130BiochemistryEpitopeCell biologyEndocrinologyInternal medicineLeukemia inhibitory factor receptor bindingmedicinebiology.proteinLeukemia Inhibitory Factor Receptor alpha SubunitBinding siteMolecular BiologyLeukemia inhibitory factorJournal of Biological Chemistry
researchProduct

BENZODIAZEPINE RECEPTOR BINDING IN RAT BRAIN AND RAT SPINAL CORD MEMBRANES

1978

medicine.medical_specialtymedicine.anatomical_structureEndocrinologyMembraneChemistryInternal medicinemedicineSpinal cordRat brainBenzodiazepine receptor binding
researchProduct